Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors
US9333234B2 · kind B2 · utility
1Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2013 |
| Grant date | May 10, 2016 |
| Priority date | — |
| Expiry date | Apr 10, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a combination which comprises (a) a somatostatin analog and (b) a 11beta-hydroxylase inhibitor; each in free form or in the form of a pharmaceutical acceptable salt thereof; the use of such a combination for the preparation of a medicament for the treatment of diseases associated with increased stress hormone levels; a commercial package or product comprising such a combination; and to a method of treatment of a warm-blooded animal, especially a human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.